Short Oral Presentation Award 2022: Recombinant Lactic Acid Bacteria for IBD Therapy
Abida Zahirović, Jozef Stefan Institute, Slovenia, was awarded during Targeting Microbiota 2022 for her talk on "Recombinant Lactic Acid Bacteria for Therapy of Inflammatory Bowel Disease".
Dr. Zahirović shared with the International Society of Microbiota that her future research will be focussed on development of targeted bacterial delivery systems for anticancer agents.
She state: "In my PostDoc project, I aim to engineer lactic acid bacteria to display cancer cell-specific ligand on their surface and concomitantly secrete cytotoxic protein to achieve selective killing of cancer cells. In vivo tumour-targeting bacteria can increase intratumoral accumulation of a cytotoxic protein, thus restricting its activity to the tumour and sparing healthy tissue from toxic side-effects."
The Scientific Committee congratulates Dr. Zahirović again for her exceptional talk and look forward to hearing the outcome of her research in future meetings.
Targeting Microbiota 2022 Congress
October 19-21, 2022- Paris, France
www.microbiota-site.com
